DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /GPCR & G Protein TargetsGPCR & G Protein Targets
  5. /Glucagon ReceptorGlucagon Receptor
  6. /AdomeglivantAdomeglivant
Chemical structure of CAS 1488363-78-5

Adomeglivant

In Stock•Starting at $240 for 5 mg•Purity ≥ 98%
CAS No.1488363-78-5
MDL No.N/A
MFC32H36F3NO4
MW555.60
InChI KeyFASLTMSUPQDLIB-MHZLTWQESA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$240In Stock
10 mg98%$373In Stock
25 mg98%$741In Stock
50 mg98%$1131In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1488363-78-5
Product NameAdomeglivant
Heavy Atom Count40Rotatable Bond Count10
Atom Stereo Count1Bond Stereo Count0
HBA3HBD2
TPSA75.630 ŲCharge0
Exact Mass555.25964Complexity1301.25
pKa3.108XLogP7.935

Related Articles

Studies related to this compound and its mechanism of action

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.

Diabetes care • Vol. 39, Issue 7 • 2016
PMID: 26681715DOI: 10.2337/dc15-1643

Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes.

Diabetes, obesity & metabolism • Vol. 17, Issue 4 • 2015
PMID: 25656305DOI: 10.1111/dom.12446

Documentation

Similar Products

  • Pf-06291874

    CAS No.1393124-08-7

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact